| 000 | 01581 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515125055.0 | ||
| 264 | 0 | _c20090602 | |
| 008 | 200906s 0 0 eng d | ||
| 022 | _a1473-6322 | ||
| 024 | 7 |
_a10.1097/ACI.0b013e328306a007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFinegold, Ira | |
| 245 | 0 | 0 |
_aIssues in stinging insect allergy immunotherapy: a review. _h[electronic resource] |
| 260 |
_bCurrent opinion in allergy and clinical immunology _cAug 2008 |
||
| 300 |
_a343-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAllergens _xadverse effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAntibodies, Anti-Idiotypic |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aArthropod Venoms _xadverse effects |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 |
_aDesensitization, Immunologic _xadverse effects |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHymenoptera |
| 650 | 0 | 4 |
_aHypersensitivity, Immediate _xchemically induced |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 |
_aInsect Bites and Stings _ximmunology |
| 650 | 0 | 4 |
_aInsect Proteins _xadverse effects |
| 650 | 0 | 4 |
_aMastocytosis, Systemic _xdrug therapy |
| 650 | 0 | 4 | _aOmalizumab |
| 650 | 0 | 4 | _aWithholding Treatment |
| 773 | 0 |
_tCurrent opinion in allergy and clinical immunology _gvol. 8 _gno. 4 _gp. 343-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/ACI.0b013e328306a007 _zAvailable from publisher's website |
| 999 |
_c18079362 _d18079362 |
||